Literature DB >> 31955209

Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.

Viral N Shah1, Ryan Bailey2, Mengdi Wu2, Nicole C Foster2, Rodica Pop-Busui3, Michelle Katz4, Jill Crandall5, Fida Bacha6, Kristen Nadeau1, Ingrid Libman7, Paul Hiers8, Kara Mizokami-Stout3, Linda A DiMeglio9, Jennifer Sherr10, Richard Pratley11, Shivani Agarwal12, Janet Snell-Bergeon1, Eda Cengiz10, Sarit Polsky6, Sanjeev N Mehta4.   

Abstract

CONTEXT: Cardiovascular disease (CVD) is a major cause of mortality in adults with type 1 diabetes.
OBJECTIVE: We prospectively evaluated CVD risk factors in a large, contemporary cohort of adults with type 1 diabetes living in the United States.
DESIGN: Observational study of CVD and CVD risk factors over a median of 5.3 years.
SETTING: The T1D Exchange clinic network. PATIENTS: Adults (age ≥ 18 years) with type 1 diabetes and without known CVD diagnosed before or at enrollment. MAIN OUTCOME MEASURE: Associations between CVD risk factors and incident CVD were assessed by multivariable logistic regression.
RESULTS: The study included 8,727 participants (53% female, 88% non-Hispanic white, median age 33 years [interquartile ratio {IQR} = 21, 48], type 1 diabetes duration 16 years [IQR = 9, 26]). At enrollment, median HbA1c was 7.6% (66 mmol/mol) (IQR = 6.9 [52], 8.6 [70]), 33% used a statin, and 37% used blood pressure medication. Over a mean follow-up of 4.6 years, 325 (3.7%) participants developed incident CVD. Ischemic heart disease was the most common CVD event. Increasing age, body mass index, HbA1c, presence of hypertension and dyslipidemia, increasing duration of diabetes, and diabetic nephropathy were associated with increased risk for CVD. There were no significant gender differences in CVD risk.
CONCLUSION: HbA1c, hypertension, dyslipidemia and diabetic nephropathy are important risk factors for CVD in adults with type 1 diabetes. A longer follow-up is likely required to assess the impact of other traditional CVD risk factors on incident CVD in the current era. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2020        PMID: 31955209      PMCID: PMC7341163          DOI: 10.1210/clinem/dgaa015

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).

Authors:  Rachel G Miller; Tina Costacou; Trevor J Orchard
Journal:  Diabetes       Date:  2018-11-08       Impact factor: 9.461

2.  Trends in cardiovascular risk factor management in type 1 diabetes by sex.

Authors:  Krystal K Swasey; Trevor J Orchard; Tina Costacou
Journal:  J Diabetes Complications       Date:  2018-01-10       Impact factor: 2.852

Review 3.  11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

4.  State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.

Authors:  Nicole C Foster; Roy W Beck; Kellee M Miller; Mark A Clements; Michael R Rickels; Linda A DiMeglio; David M Maahs; William V Tamborlane; Richard Bergenstal; Elizabeth Smith; Beth A Olson; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2019-01-18       Impact factor: 6.118

Review 5.  Cardiovascular complications of type 1 diabetes: update on the renal link.

Authors:  Trevor J Orchard; Tina Costacou
Journal:  Acta Diabetol       Date:  2016-12-19       Impact factor: 4.280

6.  Hemoglobin A1c Level and Cardiovascular Disease Incidence in Persons With Type 1 Diabetes: An Application of Joint Modeling of Longitudinal and Time-to-Event Data in the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  Rachel G Miller; Stewart J Anderson; Tina Costacou; Akira Sekikawa; Trevor J Orchard
Journal:  Am J Epidemiol       Date:  2018-07-01       Impact factor: 4.897

7.  Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control.

Authors:  Janet K Snell-Bergeon; John E Hokanson; Lisa Jensen; Todd MacKenzie; Gregory Kinney; Dana Dabelea; Robert H Eckel; James Ehrlich; Satish Garg; Marian Rewers
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

8.  Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes.

Authors:  Christel Hero; Araz Rawshani; Ann-Marie Svensson; Stefan Franzén; Björn Eliasson; Katarina Eeg-Olofsson; Soffia Gudbjörnsdottir
Journal:  Diabetes Care       Date:  2016-04-18       Impact factor: 19.112

9.  The triglycerides-to-HDL-cholesterol ratio and cardiovascular disease risk in obese patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).

Authors:  Katarina Eeg-Olofsson; Soffia Gudbjörnsdottir; Björn Eliasson; Björn Zethelius; Jan Cederholm
Journal:  Diabetes Res Clin Pract       Date:  2014-07-22       Impact factor: 5.602

10.  Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases.

Authors:  Susanna C Larsson; Alice Wallin; Niclas Håkansson; Otto Stackelberg; Magnus Bäck; Alicja Wolk
Journal:  Int J Cardiol       Date:  2018-03-24       Impact factor: 4.164

View more
  10 in total

1.  Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study.

Authors:  Soraya Soulimane; Beverley Balkau; Yakima D Vogtschmidt; Monika Toeller; John H Fuller; Sabita S Soedamah-Muthu
Journal:  Diabetologia       Date:  2022-04-12       Impact factor: 10.460

Review 2.  The Impact of Diabetes on Vascular Disease: Progress from the Perspective of Epidemics and Treatments.

Authors:  Runyang Liu; Lihua Li; Chen Shao; Honghua Cai; Zhongqun Wang
Journal:  J Diabetes Res       Date:  2022-04-08       Impact factor: 4.061

Review 3.  Lipid management for cardiovascular risk reduction in type 1 diabetes.

Authors:  Shoshana Tell; Kristen J Nadeau; Robert H Eckel
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-08       Impact factor: 3.626

Review 4.  Therapeutic Approach of Flavonoid in Ameliorating Diabetic Cardiomyopathy by Targeting Mitochondrial-Induced Oxidative Stress.

Authors:  Syaifuzah Sapian; Izatus Shima Taib; Jalifah Latip; Haliza Katas; Kok-Yong Chin; Nor Anizah Mohd Nor; Fatin Farhana Jubaidi; Siti Balkis Budin
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

5.  Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes.

Authors:  Benjamin Udoka Nwosu; Sadichchha Parajuli; Krish Khatri; Gabrielle Jasmin; Layana Al-Halbouni; Austin F Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-17       Impact factor: 6.055

6.  The Theory of Hyperlipidemic Memory of Type 1 Diabetes.

Authors:  Benjamin Udoka Nwosu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 6.055

7.  Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.

Authors:  Viral N Shah; Ryan Bailey; Mengdi Wu; Nicole C Foster; Rodica Pop-Busui; Michelle Katz; Jill Crandall; Fida Bacha; Kristen Nadeau; Ingrid Libman; Paul Hiers; Kara Mizokami-Stout; Linda A DiMeglio; Jennifer Sherr; Richard Pratley; Shivani Agarwal; Janet Snell-Bergeon; Eda Cengiz; Sarit Polsky; Sanjeev N Mehta
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

8.  Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus.

Authors:  Ornella Bosco; Barbara Vizio; Gabriella Gruden; Martina Schiavello; Bartolomeo Lorenzati; Paolo Cavallo-Perin; Isabella Russo; Giuseppe Montrucchio; Enrico Lupia
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

9.  Variants translating reduced expression of the beta estrogen receptor gene were associated with increased carotid intima media thickness: A cross-sectional study in late postmenopausal women.

Authors:  Antonio-Jorge Cano-Marquina; Miguel-Ángel García-Pérez; Juan J Tarín; Alicia M Maceira; Juan Cosín-Sales; Antonio Cano
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

10.  Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine.

Authors:  Nicola Tecce; Maria Masulli; Roberta Lupoli; Giuseppe Della Pepa; Lutgarda Bozzetto; Luisa Palmisano; Angela Albarosa Rivellese; Gabriele Riccardi; Brunella Capaldo
Journal:  Cardiovasc Diabetol       Date:  2020-10-03       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.